Equities

Evolent Health Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Evolent Health Inc

Actions
Health CareHealth Care Providers
  • Price (USD)2.77
  • Today's Change-0.01 / -0.36%
  • Shares traded1.66m
  • 1 Year change-73.67%
  • Beta0.2604
Data delayed at least 15 minutes, as of Feb 19 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments104193188
Total Receivables, Net415447255
Total Inventory------
Prepaid expenses293021
Other current assets, total591414
Total current assets607684478
Property, plant & equipment, net7990137
Goodwill, net1,1371,117723
Intangibles, net680752443
Long term investments8.594.904.48
Note receivable - long term------
Other long term assets------
Total assets2,5442,6801,817
LIABILITIES
Accounts payable964857
Accrued expenses127216171
Notes payable/short-term debt17100
Current portion long-term debt/capital leases------
Other current liabilities, total321410205
Total current liabilities716674433
Total long term debt491597413
Total debt662597413
Deferred income tax11134.74
Minority interest------
Other liabilities, total136150107
Total liabilities1,3531,434958
SHAREHOLDERS EQUITY
Common stock1.171.151.02
Additional paid-in capital1,8041,8081,487
Retained earnings (accumulated deficit)(781)(719)(606)
Treasury stock - common(21)(21)(21)
Unrealized gain (loss)------
Other equity, total(1.75)(1.26)(1.18)
Total equity1,1911,246859
Total liabilities & shareholders' equity2,5442,6801,817
Total common shares outstanding115114100
Treasury shares - common primary issue1.541.541.54
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.